Hematological toxicities associated with amphotericin B formulations.
about
Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.IP3-4 kinase Arg1 regulates cell wall homeostasis and surface architecture to promote clearance of Cryptococcus neoformans infection in a mouse model.
P2860
Hematological toxicities associated with amphotericin B formulations.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Hematological toxicities associated with amphotericin B formulations.
@ast
Hematological toxicities associated with amphotericin B formulations.
@en
type
label
Hematological toxicities associated with amphotericin B formulations.
@ast
Hematological toxicities associated with amphotericin B formulations.
@en
prefLabel
Hematological toxicities associated with amphotericin B formulations.
@ast
Hematological toxicities associated with amphotericin B formulations.
@en
P2860
P1433
P1476
Hematological toxicities associated with amphotericin B formulations.
@en
P2093
Alessandro C Pasqualotto
Franciane B da Rosa
P2860
P304
P356
10.3109/10428194.2015.1010080
P577
2015-01-28T00:00:00Z